DE69905878T2 - Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen - Google Patents

Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen

Info

Publication number
DE69905878T2
DE69905878T2 DE69905878T DE69905878T DE69905878T2 DE 69905878 T2 DE69905878 T2 DE 69905878T2 DE 69905878 T DE69905878 T DE 69905878T DE 69905878 T DE69905878 T DE 69905878T DE 69905878 T2 DE69905878 T2 DE 69905878T2
Authority
DE
Germany
Prior art keywords
sclareolide
preparations containing
microbial infections
disorders
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69905878T
Other languages
English (en)
Other versions
DE69905878D1 (de
Inventor
Ven Subbiah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Avoca Inc
Original Assignee
RJ Reynolds Tobacco Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RJ Reynolds Tobacco Co filed Critical RJ Reynolds Tobacco Co
Application granted granted Critical
Publication of DE69905878D1 publication Critical patent/DE69905878D1/de
Publication of DE69905878T2 publication Critical patent/DE69905878T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69905878T 1998-06-09 1999-05-12 Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen Expired - Lifetime DE69905878T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/094,058 US6150381A (en) 1998-06-09 1998-06-09 Methods of treating microbial infection and therapeutic formulations therefor
PCT/US1999/010534 WO1999063978A2 (en) 1998-06-09 1999-05-12 Methods of treating microbial infection and therapeutic formulations therefor

Publications (2)

Publication Number Publication Date
DE69905878D1 DE69905878D1 (de) 2003-04-17
DE69905878T2 true DE69905878T2 (de) 2003-12-04

Family

ID=22242608

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69905878T Expired - Lifetime DE69905878T2 (de) 1998-06-09 1999-05-12 Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen

Country Status (6)

Country Link
US (2) US6150381A (de)
EP (1) EP1083895B1 (de)
AT (1) ATE234089T1 (de)
AU (1) AU3902299A (de)
DE (1) DE69905878T2 (de)
WO (1) WO1999063978A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150381A (en) * 1998-06-09 2000-11-21 R.J. Reynolds Tobacco Company Methods of treating microbial infection and therapeutic formulations therefor
DE19853476A1 (de) 1998-11-19 2000-05-31 Bionorica Arzneimittel Gmbh Prolaktin-senkendes Mittel
KR100596595B1 (ko) 2000-04-04 2006-07-06 칼라 액세스, 인크. 피부 지질 장벽 기능 증진용 조성물
DE10048596A1 (de) * 2000-09-30 2002-04-25 Henkel Kgaa Entzündungshemmende Wirkstoffe
US20020142013A1 (en) * 2001-01-31 2002-10-03 Maes Daniel H. Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function
US20030072777A1 (en) * 2001-10-05 2003-04-17 Maes Daniel H. Combinatorial anti-acne compositions
US20040018220A1 (en) * 2002-07-26 2004-01-29 Chiou Consulting, Inc. Aqueous compositions for facial cosmetics
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
KR100851694B1 (ko) * 2004-04-30 2008-08-11 카오 가부시키가이샤 주름 개선제 및 피부 화장료
US7588759B2 (en) * 2004-12-17 2009-09-15 Avoca, Inc. Compositions comprising sclareol or derivatives thereof and uses thereof
EP2014276A1 (de) 2007-06-20 2009-01-14 Cognis IP Management GmbH Kosmetische Zusammensetzungen mit Sclareolid- und Hesperidin-Methyl-Chalcon
US20100317635A1 (en) 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
EP2789369B1 (de) 2013-04-14 2018-06-06 Symrise AG Eine Zubereitung zur Aufhellung von Haut und Haaren
EP3097905B1 (de) 2015-05-28 2020-11-04 Symrise AG Kosmetische zubereitungen
BR112018074709B1 (pt) 2016-05-30 2022-01-18 Symrise Ag Medicamento compreendendo esclareolido, método não terapêutico para tratamento da hiperpigmentação induzida por luz visível na faixa de 400 nm a 700 nm, e uso cosmético não terapêutico de esclareolido
CN109789066A (zh) 2016-06-30 2019-05-21 西姆莱斯股份公司 含有间苯二酚衍生物的药物和化妆组合物
CA3036773A1 (en) * 2016-09-14 2018-03-22 Grace Breeding Ltd. Compositions comprising a non-pathogenic bacteria and methods for protecting plant and animal hosts from fungal, bacterial and viral diseases
KR102470030B1 (ko) * 2018-05-28 2022-11-23 주식회사 엘지생활건강 구강질환 예방 또는 치료용 조성물
CN112006970B (zh) * 2020-08-14 2021-10-22 珀莱雅化妆品股份有限公司 一种抗瘙痒功效组合物及其制备方法与应用
WO2023167867A1 (en) * 2022-03-01 2023-09-07 Isp Investments Llc Sclareol or sclareolide for improving scalp conditions and hair growth

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3060172A (en) 1959-04-29 1962-10-23 Reynolds Tobacco Co R Process for recovering sclareol from clary sage
US3952099A (en) 1973-03-13 1976-04-20 The Procter & Gamble Company Dermatological compositions
US4130667A (en) 1976-01-12 1978-12-19 The Procter & Gamble Company Dermatological compositions
GB2068228B (en) 1980-01-24 1984-02-29 Janssen Pharmaceutica Nv Anti-microbial compositions for the topical treatment of acne vulgaris
US4537776A (en) 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
US4837378A (en) 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
JP2700070B2 (ja) * 1988-06-10 1998-01-19 株式会社資生堂 グラム陽性嫌気性細菌用抗菌剤及びそれを用いた皮膚外用剤、口腔用組成物
US4983637A (en) * 1988-06-24 1991-01-08 Stephen Herman Method for treating viral infection of HIV
JPH0779682B2 (ja) 1989-08-28 1995-08-30 インターナショナル フレーバーズ アンド フレーグランシィズ インコーポレーテッド 微生物の生物学的に純粋な培養物、ラクトン生成方法、ジオール生成方法、化合物生成方法および環状エーテルの生成方法
US5212078A (en) 1989-08-28 1993-05-18 International Flavors And Fragrances Inc. Process for producing a lactone
US4970163A (en) 1989-08-28 1990-11-13 International Flavors & Fragrances Inc. Process for producing diol and lactone and microorganisms capable of same
US5155029A (en) 1989-08-28 1992-10-13 International Flavors & Fragrances Inc. Process for producing a cyclic ether
DE3942358A1 (de) 1989-12-21 1991-06-27 Henkel Kgaa Verfahren zur herstellung von sclareolid
EP0636126B1 (de) 1992-04-16 1997-01-08 Henkel Kommanditgesellschaft auf Aktien Verfahren zur herstellung von sclareolid
US5358752A (en) * 1993-02-23 1994-10-25 Norac Technologies Inc. Skin care composition
GB9500024D0 (en) 1995-01-04 1995-03-01 Sod Conseils Rech Applic Treatment of excessive cell proliferation disorders
US5773005A (en) * 1995-06-09 1998-06-30 Takahashi; Hidehiko Purified flavonoid and diterpene 5α-reductase inhibitors from thuja orientalis for androgen-related diseases
JPH10298070A (ja) * 1997-04-22 1998-11-10 Toagosei Co Ltd 抗真菌剤
US6150381A (en) * 1998-06-09 2000-11-21 R.J. Reynolds Tobacco Company Methods of treating microbial infection and therapeutic formulations therefor

Also Published As

Publication number Publication date
ATE234089T1 (de) 2003-03-15
WO1999063978A3 (en) 2000-04-13
WO1999063978A2 (en) 1999-12-16
US6331551B1 (en) 2001-12-18
EP1083895A2 (de) 2001-03-21
AU3902299A (en) 1999-12-30
US6150381A (en) 2000-11-21
EP1083895B1 (de) 2003-03-12
DE69905878D1 (de) 2003-04-17

Similar Documents

Publication Publication Date Title
DE69905878D1 (de) Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen
DK0725779T3 (da) Hidtil ukendte (R)-5-Carbamoyl-8-fluor-3-N,N-disubstitueret-amino-3,4-dihydro-2H-1-benzopyraner
DE59509751D1 (de) Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
NO20025450D0 (no) Ny farmasöytisk sammensetning
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
FR2856294B1 (fr) Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
BR0109211A (pt) Compostos com atividade 5-ht1a úteis para o tratamento de distúrbios da retina externa
PT932613E (pt) Expressao de bloqueio de factoes de virulencia em s. aureus
DE69729183D1 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
DE60117606D1 (de) Orale zusammensetzungen zur behandlung von kopfhauterkrankungen
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
WO2001091796A8 (en) Methods, compounds and compositions for treating gout
NO20044530L (no) Fremgangsmate for behandling av kognitive forstyrrelser
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
DE69132575T2 (de) Sampangin-derivate zur verwendung als antimykotische und antimykobakterielle wirkstoffe
ES2171976T3 (es) Formulacion de ciclosporina.
ATE322244T1 (de) Verwendung von polyaminosäurederivaten zur behandlung von seborrhoe und verwandten hautstörungen
ATE216891T1 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
DK1232173T3 (da) Nye fusidinsyrederivater
TR200101476T2 (tr) N-ikameli azabisikloaklan türevlerinin merkezi sinir sistemi bozukluklarının tedavisinde kullanılması
DE60113704D1 (de) Verwendung einer kombination von nicotinsäuren oder deren derivaten und riboflavin zur herstellung eines arzneimittels zur behandlung von primären kopfschmerzen
ATE402178T1 (de) Substituierte 5,6,6a,11b-tetrahydro-7-oxa-5-aza- benzoäcüfluoren-6-carbonsäurederivate als nmda- antagonisten

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: AVOCA INC., MERRY HILL, N.C., US

8364 No opposition during term of opposition